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rather than looking for structural overlaps among SAR models, Email: rsnkranz@pitt.edu we chose 10 000 chemical representatives of the 'universe of The mechanistic relationship of the inhibition of gap juncchemicals' (24) . The various biological/toxicological properties tional intercellular communication (GJIC) to other toxicoof these chemicals are predicted using validated SAR models. logical phenomena was explored using a recently developed
The prevalence of chemicals predicted to possess two toxicolomethod that models the properties of a large population of gical properties simultaneously is then determined and commolecules chosen to represent the 'universe of chemicals'.
pared with that expected. The rationale of the approach as The analyses indicate that inhibition of GJIC is strongly well as the interpretation of the results are described below. linked to the carcinogenic process in rodents, to cellular We applied this approach to the phenomenon of inhibition but not systemic toxicity, to biological phenomena that may of GJIC to determine whether it demonstrated the expected involve inflammatory processes and to development effects.
interactions and/or whether in addition it generated new testable The inhibition of GJIC appears not to be associated with mechanistic hypotheses. genotoxic mechanisms. With respect to cancer causation, integration of the analyses suggests that inhibition of GJIC Materials and methods is involved in non-genotoxic cancer induction or in the Introduction (27, 28) . In each instance the cut-offs used to predict the activity of the 10 000 chemicals (24) were set to ensure that the positive (or negative) predictive As a result of the perseverance of Trosko and associates power of the test was optimal.
(1-3), of Yamasaki et al. (4) and of Klaunig and Ruch Each of the SAR models used herein had been characterized (22) with (5), the role of inhibition of gap junctional intercellular respect to its ability to predict the activity of chemicals external to the model communication (GJIC) in toxicological phenomena has gained (see Table I ).
acceptance. The more recent findings of the molecular targets SAR models of inhibition of GJIC, i.e. the connexins, have led to the The validated SAR models used for these studies have been described recognition of the mechanism of this inhibition (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (48, 49) . Systemic toxicity in rats models are rarely unbiased representatives of the 'universe of was defined as an LD 50 ഛ7.3 mmol/kg (this cut-off value was chosen chemicals'. This is due to the fact that toxicological data upon arbitrarily as it allowed separation of the chemicals into two groups of equal which a specific SAR model may be based are usually not size). The SAR model was derived from data provided by the US Food and Drug Agency.
derived from a coherent toxicological testing scheme. Rather, such models are based upon the data available in the peer
The chemical diversity approach: rationale reviewed literature. Usually, the data are limited to the results
The procedure is based upon the premise that the mechanistic relationship between biological phenomena can be derived from knowledge of the of about 300 chemicals (22) . Accordingly, it may be difficult prevalence of chemicals which give identical responses in assays designed to to extrapolate and to generalize based solely on comparisons probe that relationship. Thus, at the time the electrophilic theory of cancer of SAR models which are based on restricted samplings causation was recognized (50) and the dogma that 'carcinogens are mutagens' of chemical classes. In order to overcome this potential (51) led to the development of surrogate tests for putative carcinogens, we discovered significant experimental overlaps using rodent carcinogens and genotoxicants. However, further studies clearly found that a significant number Abbreviations: GJIC, gap junctional intercellular communication; SAR, structure-activity relationship.
of non-mutagens also induced cancers in rodents. The basis of 'non-genotoxic' carcinogenesis is still under active investigation but clearly it derives from a describing structure-activity relationships. Moreover, while reliable databases of toxicological models, when available, are usually limited to 200-300 number of different mechanisms. Still, based upon the above premise, we should be able to gain a mechanistic insight into this phenomenon by chemicals, the approach used herein predicts the toxicological profiles of 10 000 chemicals representative of the 'universe of chemicals' (23) . While no evaluating the concordance, or lack thereof, between non-genotoxicants that induce cancers in rodents and agents that cause non-genotoxic phenomena SAR model is perfectly predictive when applied to a population of 10 000 chemicals, provided the sensitivity and specificity are approximately equal (e.g. peroxisome proliferation, mitogenesis and binding to the estrogen receptor). Thus, an evaluation of the toxicological profiles of a population of we can expect that the overall prevalence will reflect the true distribution. This in turn will allow a determination of the significance of the observed chemicals might reveal significant associations between 'non-genotoxic' inducers of cancers and inducers of another toxicological phenomenon. The joint prevalences. The approach can be used to confirm specific hypotheses (e.g. the elecobserved prevalence of chemicals that induce both phenomena could then be compared with the prevalence expected, if it is assumed that the two trophilic theory of cancer causation) as well as to generate new (knowledgebased) hypotheses driven solely by the data and the availability of appropriate phenomena are unrelated (i.e. the null hypothesis). If the observed prevalence is significantly greater than the expected one, then it can be concluded that SAR models. the two phenomena are related to one another mechanistically. (Similarly, if the observed prevalence is significantly lower than the expected one, it
Results and discussion
suggests that the two phenomena are antagonistic with one another, e.g. they could compete for an active site.)
The impetus for the development of assays for inhibition of
In implementing such an approach, it quickly became obvious that there is GJIC was based upon the insight of Trosko et al. ( 3) that this a scarcity of experimental data on the same chemicals across a variety of endphenomenon could be a measure of tumor promotion as well points. Hence, the significance of the observed joint prevalences cannot be ascertained. The current approach was devised to overcome this shortcoming.
as of the abolition of contact inhibition among adjacent cells, It is based upon the availability of characterized and validated models a phenomenon that is associated with cancer promotion and progression. Indeed, our earlier studies of structural overlaps between SAR models of carcinogenicity and inhibition of GJIC (21) showed a significant commonality between these Table I . Performance characteristics of SAR models phenomena. In the present study, the chemicals that were
Model Predictivity predicted to be rodent carcinogens as well as inhibitors of GJIC showed the greatest deviation (n ϭ 239) from independ-
Inhibition of GJIC 70%
ence (see Table II GJIC are also, to a large extent, characterized by being lipophilic (21) . Conceivably, these lipophilic inhibitors of GJIC GJIC, gap junctional intercellular communication. . Observed refers to the number of chemicals that are potential inhibitors of GJIC as well as possessing the potential to cause another toxicological effect. Expected indicates the prevalence expected if the two phenomena are assumed to be unrelated (i.e. null hypotheses).
could distort the Ah receptor, thus not allowing the normal reported to be irritants as well as inflammatory agents (56-59) and by the finding that inhibition of GJIC may be mediated ligand to bind. In that connection, it is interesting to note that inhibitors of GJIC are related to agents that are skin permeable by an arachidonic acid-sensitive mechanism (60) . With respect to systemic toxicity, it is noteworthy that ( Table II) . The latter phenomenon has also been shown to be associated with lipophilicity (52, 53) . inhibition of GJIC is not associated with even moderately toxic substances, i.e. agents with LD 50 values below 7.3 mmol/ In our previous study (21) , inhibition of GJIC was shown to display a mechanistic similarity to mutagenicity, albeit the kg. This is consistent with the spectrum of toxicological effects associated with inhibition of GJIC, e.g. carcinogenicity and effect was significantly less than the commonality between inhibition of GJIC and carcinogenicity. We attributed the developmental and inflammatory effects. Expression of each of these requires survival of the test object. On the other hand, relationship between mutagenicity and inhibition of GJIC not to a common causality, but rather to the fact that the two at the cellular level, inhibitors of GJIC are significantly related to toxicity to both cultured HeLa and BALB/c-3T3 cells. This phenomena may both involve a nucleophilic target, albeit they are different, i.e. attack on DNA in the case of the former and may be related to the observation that many inhibitors of GJIC are lipophilic (21) , which is a recognized mechanism of on connexin in the latter. In the present study, using a more sensitive procedure, we find that there is only a slight deviation toxicity. Moreover, cell toxicity has been investigated as a mechanistic basis for epigenetic carcinogenesis (3). Other from the expected prevalence (Table II) and it does not reach statistical significance. This finding was confirmed by studies have suggested that cellular toxicity and the resulting mitogenesis and cell proliferation may provide an alternative examining the overlap between inhibition of GJIC and induction of SOS DNA repair (the Chromotest), which, like mutamechanism of cancer causation (61) (62) (63) (64) . The possibility that inhibitors of GJIC possess inherent cytotoxic potential would genicity, is a consequence of an electrophilic attack on DNA. That overlap also did not reach statistical significance (Table  provide an additional link between this phenomenon and carcinogenesis. II). These findings suggest that the approach used herein may provide further discrimination between association and
The present study, using refined methodologies, independently extends an earlier approach based upon overlaps among causality with respect to the mechanism of toxicological activity.
SAR models (21) to assess mechanistic similarities among toxicological phenomena. With respect to the phenomenon Inhibition of GJIC overlaps with human and hamster developmental toxicity. This may well reflect the observation that of inhibition of GJIC, the results reported herein provide independent confirmation that inhibition of GJIC is related to alterations in the function and/or presence of connexins, i.e. the target of inhibition of GJIC, results in developmental carcinogenesis as well as to induction of developmental effects. A number of observations appear novel and deserve further effects (16) (17) (18) (19) (20) . Moreover, it is noteworthy that the extent of overlap between inhibition of GJIC is significantly lower for investigation: (i) a putative relationship between inhibition of GJIC and inflammatory processes; (ii) a possible direct human than it is for hamster developmental toxicants (P Ͼ 0.0001). This possibly reflects the fact that the extensive involvement of inhibition of GJIC in certain aspects of cellular toxicity that may result in mitogenesis and subsequent cancer prescreening that precedes the introduction into human usage of new products (54) may include toxicological tests that induction by a non-genotoxic mechanism. The present findings offer persuasive evidence that inhibition of GJIC is not the eliminate from consideration a number of classes of inhibitors of GJIC and therefore of putative human developmental result of a genotoxic event. toxicants. Obviously, this is not the situation with respect to chemicals tested in hamsters (41) , wherein no such prescreen Acknowledgements was imposed. In fact, a rodent developmental toxicity screen
The SAR method used herein (CASE/MULTICASE) was made available free may have been used to eliminate some of the agents that There was a significantly higher than expected prevalence of a number of acute toxicological effects such as allergic References contact dermatitis, ocular irritation, sensory irritation and respiratory hypersensitivity associated with inhibition of GJIC
